QQQ   352.08 (-0.60%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.35 (-0.71%)
BABA   85.63 (-0.33%)
AMD   97.00 (+1.08%)
T   14.81 (-1.40%)
F   12.28 (-1.21%)
MU   67.07 (-1.28%)
CGC   0.86 (-7.06%)
GE   110.42 (+0.45%)
DIS   79.32 (-0.91%)
AMC   7.65 (-3.29%)
PFE   31.98 (-1.30%)
PYPL   56.77 (-3.67%)
NFLX   376.94 (-0.61%)
QQQ   352.08 (-0.60%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.35 (-0.71%)
BABA   85.63 (-0.33%)
AMD   97.00 (+1.08%)
T   14.81 (-1.40%)
F   12.28 (-1.21%)
MU   67.07 (-1.28%)
CGC   0.86 (-7.06%)
GE   110.42 (+0.45%)
DIS   79.32 (-0.91%)
AMC   7.65 (-3.29%)
PFE   31.98 (-1.30%)
PYPL   56.77 (-3.67%)
NFLX   376.94 (-0.61%)
QQQ   352.08 (-0.60%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.35 (-0.71%)
BABA   85.63 (-0.33%)
AMD   97.00 (+1.08%)
T   14.81 (-1.40%)
F   12.28 (-1.21%)
MU   67.07 (-1.28%)
CGC   0.86 (-7.06%)
GE   110.42 (+0.45%)
DIS   79.32 (-0.91%)
AMC   7.65 (-3.29%)
PFE   31.98 (-1.30%)
PYPL   56.77 (-3.67%)
NFLX   376.94 (-0.61%)
QQQ   352.08 (-0.60%)
AAPL   169.54 (-1.41%)
MSFT   310.14 (-0.64%)
META   292.47 (-2.17%)
GOOGL   129.16 (+0.46%)
AMZN   125.37 (-0.48%)
TSLA   236.13 (-3.27%)
NVDA   418.00 (-0.26%)
NIO   8.35 (-0.71%)
BABA   85.63 (-0.33%)
AMD   97.00 (+1.08%)
T   14.81 (-1.40%)
F   12.28 (-1.21%)
MU   67.07 (-1.28%)
CGC   0.86 (-7.06%)
GE   110.42 (+0.45%)
DIS   79.32 (-0.91%)
AMC   7.65 (-3.29%)
PFE   31.98 (-1.30%)
PYPL   56.77 (-3.67%)
NFLX   376.94 (-0.61%)
NASDAQ:AVGR

Avinger (AVGR) Stock Forecast, Price & News

$6.76
-0.85 (-11.17%)
(As of 01:56 PM ET)
Compare
Today's Range
$6.41
$7.90
50-Day Range
$4.13
$69.45
52-Week Range
$4.14
$24.30
Volume
415,852 shs
Average Volume
660,352 shs
Market Capitalization
$4.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.00

Avinger MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
242.9% Upside
$24.00 Price Target
Short Interest
Healthy
1.39% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.41mentions of Avinger in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($19.79) to ($8.70) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.33 out of 5 stars


AVGR stock logo

About Avinger (NASDAQ:AVGR) Stock

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, including Ocelot and Tigereye, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. Further, the company develops IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is headquartered in Redwood City, California.

AVGR Price History

AVGR Stock News Headlines

Avinger Raises $5.3 Million via At-The-Market Facility
Windfall profits possible with this under-the-radar lithium stock.
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Avinger (NASDAQ:AVGR) Coverage Initiated by Analysts at StockNews.com
Avinger, Inc. (NASDAQ:AVGR) Short Interest Update
What's Going On With Avinger Inc. Stock Today?
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Avinger jumps 28%, enters ATM equity offering
Avinger Stock Is Soaring Again: What's Going On?
Avinger (NASDAQ:AVGR) & Azenta (NASDAQ:AZTA) Head-To-Head Comparison
Avinger Inc
Avinger (AVGR) Receives a Buy from H.C. Wainwright
Avinger Reports Second Quarter 2023 Results
See More Headlines
Receive AVGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avinger and its competitors with MarketBeat's FREE daily newsletter.

AVGR Company Calendar

Last Earnings
7/27/2023
Today
9/27/2023
Next Earnings (Estimated)
11/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AVGR
Employees
71
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$24.00
High Stock Price Forecast
$24.00
Low Stock Price Forecast
$24.00
Forecasted Upside/Downside
+245.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-17,620,000.00
Net Margins
-208.86%
Pretax Margin
-208.86%

Debt

Sales & Book Value

Annual Sales
$8.27 million
Book Value
$8.36 per share

Miscellaneous

Free Float
666,000
Market Cap
$5.00 million
Optionable
Not Optionable
Beta
1.62
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Jeffrey M. Soinski (Age 61)
    Pres, CEO & Director
    Comp: $605.15k
  • Mr. Nabeel P. Subainati (Age 39)
    VP of Fin., Principal Financial Officer & Accounting Officer
    Comp: $295.85k
  • Mr. Himanshu N. Patel (Age 63)
    Chief Technology Officer
    Comp: $423.09k
  • Mr. Keith Schaefer
    Chief Operating Officer













AVGR Stock - Frequently Asked Questions

Should I buy or sell Avinger stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AVGR shares.
View AVGR analyst ratings
or view top-rated stocks.

What is Avinger's stock price forecast for 2023?

1 brokers have issued twelve-month target prices for Avinger's shares. Their AVGR share price forecasts range from $24.00 to $24.00. On average, they predict the company's share price to reach $24.00 in the next year. This suggests a possible upside of 245.3% from the stock's current price.
View analysts price targets for AVGR
or view top-rated stocks among Wall Street analysts.

How have AVGR shares performed in 2023?

Avinger's stock was trading at $16.2750 at the beginning of 2023. Since then, AVGR shares have decreased by 57.3% and is now trading at $6.95.
View the best growth stocks for 2023 here
.

Are investors shorting Avinger?

Avinger saw a decrease in short interest in the month of September. As of September 15th, there was short interest totaling 9,000 shares, a decrease of 86.3% from the August 31st total of 65,600 shares. Based on an average daily volume of 1,850,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 1.4% of the company's shares are sold short.
View Avinger's Short Interest
.

When is Avinger's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our AVGR earnings forecast
.

How were Avinger's earnings last quarter?

Avinger, Inc. (NASDAQ:AVGR) issued its quarterly earnings results on Thursday, July, 27th. The medical device company reported ($8.85) earnings per share for the quarter, missing the consensus estimate of ($7.35) by $1.50. The medical device company had revenue of $2.04 million for the quarter, compared to the consensus estimate of $2.30 million. Avinger had a negative net margin of 208.86% and a negative trailing twelve-month return on equity of 6,767.92%.

When did Avinger's stock split?

Avinger's stock reverse split on Wednesday, September 13th 2023. The 1-15 reverse split was announced on Wednesday, September 13th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, September 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Avinger own?
When did Avinger IPO?

(AVGR) raised $60 million in an IPO on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company acted as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

What is Avinger's stock symbol?

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

Who are Avinger's major shareholders?

Avinger's stock is owned by many different institutional and retail investors. Top institutional shareholders include Prosperity Wealth Management Inc. (0.63%). Insiders that own company stock include James Cullen and Nabeel Paul Subainati.
View institutional ownership trends
.

How do I buy shares of Avinger?

Shares of AVGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Avinger's stock price today?

One share of AVGR stock can currently be purchased for approximately $6.95.

How much money does Avinger make?

Avinger (NASDAQ:AVGR) has a market capitalization of $5.00 million and generates $8.27 million in revenue each year. The medical device company earns $-17,620,000.00 in net income (profit) each year or ($41.5292) on an earnings per share basis.

How can I contact Avinger?

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The official website for the company is www.avinger.com. The medical device company can be reached via phone at (650) 241-7900, via email at info@dawson3d.com, or via fax at 800-229-2696.

This page (NASDAQ:AVGR) was last updated on 9/27/2023 by MarketBeat.com Staff

My Account -